MOLINA ARTURO MD 内部人交易:近期 SEC Form 4 交易
过去 18 个月,MOLINA ARTURO MD(CIK 1398940)在 1 家公司共报告 15 笔 SEC Form 4 内部人交易(最近一笔 2026-11-17)。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-11-17 | Protagonist Therapeutics, Inc (PTGX) | Chief Medical Officer | 卖出 | 2,718 | $338,799 |
| 2026-03-27 | Protagonist Therapeutics, Inc (PTGX) | Chief Medical Officer | 买入 | 15,000 | $120,600 |
| 2026-03-27 | Protagonist Therapeutics, Inc (PTGX) | Chief Medical Officer | 卖出 | 15,000 | $1.6M |
| 2026-01-27 | Protagonist Therapeutics, Inc (PTGX) | Chief Medical Officer | 卖出 | 13,151 | $1.1M |
| 2026-01-27 | Protagonist Therapeutics, Inc (PTGX) | Chief Medical Officer | 买入 | 5,000 | $40,200 |
| 2026-01-27 | Protagonist Therapeutics, Inc (PTGX) | Chief Medical Officer | 卖出 | 5,000 | $411,400 |
| 2026-01-27 | Protagonist Therapeutics, Inc (PTGX) | Chief Medical Officer | 买入 | 5,000 | $40,200 |
| 2026-01-27 | Protagonist Therapeutics, Inc (PTGX) | Chief Medical Officer | 卖出 | 5,000 | $410,000 |
| 2026-01-21 | Protagonist Therapeutics, Inc (PTGX) | Chief Medical Officer | 卖出 | 9,514 | $784,715 |
| 2026-01-06 | Protagonist Therapeutics, Inc (PTGX) | Chief Medical Officer | 买入 | 25,600 | $0 |
| 2025-11-19 | Protagonist Therapeutics, Inc (PTGX) | Chief Medical Officer | 卖出 | 2,712 | $229,896 |
| 2025-06-11 | Protagonist Therapeutics, Inc (PTGX) | Chief Medical Officer | 买入 | 10,000 | $80,400 |
| 2025-06-11 | Protagonist Therapeutics, Inc (PTGX) | Chief Medical Officer | 卖出 | 10,000 | $555,100 |
| 2025-06-11 | Protagonist Therapeutics, Inc (PTGX) | Chief Medical Officer | 买入 | 10,000 | $80,400 |
| 2025-06-11 | Protagonist Therapeutics, Inc (PTGX) | Chief Medical Officer | 卖出 | 10,000 | $570,300 |
来源:SEC Form 4 申报文件 · 截至 2026-11-17